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Introduction
Although iron is an abundant metal, it has low bioavailability, and iron deficiency represents one of the most common nutritional deficiencies worldwide with significant implications to public health [1] . The average adult male (70 kg) has a total body iron content of approximately 4 grams, which remains relatively constant throughout adult life [2] . This is maintained by balancing loss of iron with assimilation via nutritional intake. Persistent deviation in iron intake can result in either iron deficiency, or iron overload (hemosiderosis and hemochromatosis) [2] . The most obvious manifestation of iron deficiency is anemia, but lack of iron can also have an adverse effect on the immune system [3, 4] and cognitive development [5, 6] . Iron is an essential nutrient since iron cofactors, including heme and iron-sulfur clusters, are required for the activity of a number of enzymes involved in a range of cellular processes. Furthermore, iron is also an important component of molecules that undergo redox reactions in cells [7, 8] . Anemia and iron deficiency may cause serious diseases, for example, anemia and iron deficiency are quite prevalent in patients with heart failure. In the past few years, there has been an enormous interest in the subject of iron deficiency and its management in patients with heart failure [9] .
Since leavened bread, produced using Saccharomyces cerevisiae (baker's yeast), is a staple component of diets in many areas of the world, the potential for using yeast biomass enriched with iron as a feed supplement has the potential to deliver a safe and efficient mechanism for the prevention or recovery from anemia. Previous studies have shown that iron bound to organic carriers, such as cytochrome C, catalase and other proteins and enzymes in yeast cells, are more easily absorbed and have a reduced potential to be toxic [10] . In addition, yeast biomass is known to be a good source of protein, amino acids and vitamins, and has been shown to have a positive nutritional impact in animals and humans [10] . Despite the suitability of yeast for nutrient transfer, the uptake, storage and utilization of iron in Saccharomyces cerevisiae cells is tightly regulated. In particular, the metal uptake and assimilation processes are complex and dependent on the chemistry of metal ions, specific surface properties of the organism, cell physiology and the physico-chemical influence of the environment [10] . Consequently, in this study the capacity of a baker's yeast strain to assimilate iron was determined, and the resulting iron-enriched baker's yeast was evaluated for its potential in alleviating symptoms of iron deficiency in Wistar rats.
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Materials and Methods
Preparation of iron-enriched yeast
A commercial baker's yeast strain was obtained and isolated from the local market (Aleppo, Syria). Yeast propagation was conducted in 250 ml Erlenmeyer flask containing 100 ml basal medium (20g/l glucose, 0.5g/l yeast extract, 5g/l ammonium sulphate, 1g/l potassium dihydrogen phosphate, 0.5g/l magnesium sulphate, pH adjusted to 5.2 with 5N NaOH). Yeast cultures were enriched with iron by supplementation with ammonium iron (III) citrate in concentrations of 0.5, 1, 2 and 4 % (W/V) corresponding to 16, 32, 64 and 128 mM Fe. The cultures were incubated at 30°C for 24 h, with shaking at 150 rpm. In each instance the entire cell culture was recovered by centrifugation, excess liquid was decanted and samples were desiccated using a drying oven (Memmert, Egypt). Dried yeast samples were collected and used for further analysis (iron content and as a nutritional supplement) as described below.
Evaluation of iron content in iron enriched yeast
After 24 h cultivation cultures were centrifuged (5 min, 4000 g) and the supernatant discarded. The pellet was washed three times with distilled water in order to remove loosely associated fraction of iron from yeast cell surface. Washed yeast biomass was dried at 105°C until a constant mass was achieved, and digested by adding 1 ml of 65 % (v/v) HNO 3 to 20 mg dry biomass, followed by heating for 30 min at 140°C. After cooling, samples were diluted with distilled water to a final volume of 5 ml and the content of iron was analyzed by Flame Atomic Absorption Spectrometry (FAAS) in the Agricultural Research Center, Giza, Egypt. The amount of total iron was calculated per gram of dry weight (mg Fe/g -1 dry wt.) as described previously [10] .
Animals and diets
Forty-eight newly weaned male and female Wistar rats (initial body weight, 75 -85g) were obtained and housed individually in stainless steel, wire mesh bottom cages. A 12-h light:
dark cycle and an environmental temperature of 25 ±2°C were maintained. Newly weaned rats were chosen since individuals of this age can be considered to be similar irrespective of gender; physiological, hormonal or metabolic changes are not observed between males and females at this early stage of life. This was verified in-house by analysis of data, which
showed that there was no difference between young rats based on gender distinction (data not shown). Rats were randomly assigned to one of six dietary groups (eight rats per group) as illustrated in Fig.1 . The control group was fed on basal diet containing 30mg of Fe per M A N U S C R I P T
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kilogram of diet for 56 days (total experiment time). Precise composition of the basal diet used was based on Sun et al [11] and shown below.
Iron deficiency was induced as described by Hamdaoui et al [12] with minor modifications: a low iron basal diet (3mg/Kg) was provided in conjunction with bleeding of 1-2 ml of blood every week for four weeks until the Fe and Hemoglobin reached a designated low level (109-112 g/L Hemoglobin and 3 mg body iron) . These anemic rats were assigned to five groups of 8 rats (four males and four females). Groups were examined by feeding on one of the following diets for an additional 28 days: Group 1 was fed on basal Fe-deficient diet (no iron added The mixtures of minerals and vitamins were prepared according to [11] as follows: 
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Blood analysis
Hematocrit was measured by centrifugation of blood and expressed as the volume percentage of red blood cells. Hemoglobin concentration was measured using a Hemoglobin determination kit (Biodiagnostic Inc., Egypt). Serum iron concentration and total iron binding capacity (TIBC) using iron and (TIBC) kit (Biodiagnostic Inc., Egypt).Transferrin saturation (TS) was calculated from the ratio of serum iron/TIBC.
Catalase assay
Catalase activity was determined in plasma and kidney tissue after homogenate preparation by tissue perfusion with a PBS (phosphate buffered saline) solution, pH 7.4 containing 0.16 mg / ml heparin to remove any red blood cells and clots prior to dissection. Tissue was homogenized in 5-10 ml cold buffer (50 mM potassium phosphate, pH 7.5. 1 mM EDTA) per gram of tissue;
the homogenate was then centrifuged at 10,000 rpm for 15 minutes at 4 °C. The supernatant was removed and stored on ice. If the assay was not conducted on the same day, the sample was frozen at -80°C. Catalase activity was estimated using a catalase assay kit (Biodiagnostic Inc., Egypt).
Calculation of iron bioavailability and feed efficiency
The iron (Fe) bioavailability from test meals was calculated for each animal based on initial and final body weights, the initial and the final hemoglobin concentrations, and the amount of Fe consumed during the repletion period. The initial and final concentration of hemoglobin-Fe was computed according to equations 1, 2 respectively, assuming that 7.5% of the body weight is blood and that hemoglobin contains 3.35mg Fe per gram as defined previously [12] . 
Equation (4)
Feed efficiency % = BW gained/ total food intake Where: BW gained = final BW -initial BW BW: body weight.
Tissue preparation for iron determination
After 56 days, animals were euthanized and their livers, hearts, kidneys, and spleens were removed. 1-2 g of tissue was transferred into borosilicate test tubes and concentrated nitric acid and perchloric acid were added to the contents. The contents were heated to 85°C for 24 h followed by 110°C for 5h. Digestion was determine to be complete by the appearance of a colorless solution [13] . The iron concentration of samples was measured by inductively coupled plasma emission spectrometry (ICPS-1000 II, Shimadzu, Faculty of Agriculture, Cairo University).
Histological examination of tissues
Tissues derived from liver, kidney, and heart were stained with Hematoxylin-Eosin (H&E)
for histological examination, while the spleen was stained with Perls' Prussian blue to 
Statistical analysis
All data obtained for yeast experiments reflects the mean of identical triplicate samples ± the standard error. Where appropriate, statistical variation was determined using a two tailed Student T-Test. A significant difference was identified at the 5% confidence level (P< 0.05).
For rat analysis, in each instance sample groups were comprised of 8 newly weaned 'young' individuals, with males and females considered to be identical as described previously. Data was analyzed using a two tailed Student t-test to determine significant differences between trial and control samples. A significant difference was identified at the 5% confidence level (P< 0.05). Table 1 indicate that the differences in final body weights of rats from different groups were non-significant at both 5 % and1 %, so this suggests that there is no significant difference between all treatments. On the other hand, significant increases in body weights of rats were observed in all groups, although the increase in group 1 (fed on iron deficient diet) was the least significant increase. Moreover, Table 2 shows that the increase of hemoglobin levels in all groups were significant except in group 3 (fed on diet containing iron salt plus yeast) which was non-significant at the level of 1 % and significant at 5 %. On the other hand, there was a significant increase in hemoglobin levels of rats from groups 4 and 5 when compared with other treatments groups 2 and 3; these results prove clearly that both groups 4 and 5 achieved better results than other treatments. Also when comparing hemoglobin results from groups 4 and 5 with those from control group, it was noticed that differences between hemoglobin levels of these groups and control group are M A N U S C R I P T
Statistical evaluation of different feeding treatments-Results in
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not significant but the result of group 4 was less significant (closer) to control group which give this group (treatment) the advantage on the other group (group 5).
Iron bioavailability and feed efficiency-Feed efficiency and iron bioavailability were studied and calculated during treatment period (4 weeks). Results indicate that animal groups fed on iron enriched yeast (4 and 5) gave the highest feed efficiency (10.9 %) when compared with other anemic groups (1, 2 and 3). These groups (4 and 5) gave 90.83 % of feed efficiency of control group (which was fed normally), also the feeding efficiency of groups fed on iron enriched yeast was increased 1.16 fold when compared with group 2 which was fed on basal medium plus inorganic iron salt (Fig.3A and Table 3 ).
Regarding iron bioavailability, results obtained from Table 4 and Fig.3B Blood parameters-Based on hemoglobin concentration and hematocrit value, iron in groups 4 and 5 (fed on iron enriched yeast) was more bioavailable in rats and cured iron deficiency when compared with other groups (1, 2 and 3), as shown in Table 5 . In groups 2 and 3, hemoglobin concentration was less than that in the control group, whereas the hematocrit value was also slightly less than that in control group at the end of subjected to the best treatments than other treatments, whereas group 4 also gave the best results in other blood parameters studied when compared to other groups. Fig.3C indicates that the iron restricted diet didn't affect the catalase activity in plasma during moderate iron deficiency anemia development (4 weeks) period in this experiment this may be because the period was not enough to affect the catalase activity in plasma.
Enzymatic activity of iron dependent enzyme (catalase activity)-Results shown in
Catalase activity in kidney was also studied. Fig.3D shows the catalase activity in kidney tissues of rats from different groups. In contrast of plasma, results obtained from figure 3D showed that the catalase activity in kidney tissues of anemic rats decreased. Different treatments raised the catalase activity from 70 U/g tissue in anemic rats to 90 U/g tissue in . Although the improvement was less than aimed, the previous results suggest that the treatment applied in group 4 (iron enriched yeast 15 mg Fe/g diet) is the best treatment that can be used in the treatment of iron deficiency, but it may need more time than used in this experiment (4weeks) to achieve complete recovery of catalase activity in kidney tissues. Fig.3E shows that the reduction of iron concentration in liver tissues was about 34% (from 0.93 µmol/g in control group to 0.61 µmol/g in anemic rats group 1) but it was completely recovered in group 2 to reach 1.03 µmol/g, but the highest concentration of iron was accumulated in liver tissues of rats fed on iron enriched yeast in group 4 which was 1.29µmol/g. On the other hand, iron concentration in spleen tissues shown in Fig.3Fwas gradually increased in different treatments from 1.93µmol/g in anemic rats (group 1) to 2.6µmol/g and 4.85µmol/g in groups 2 and 3 respectively, and reached its maximum of 5.9 and 6.1µmol/g in groups 4 and 5, respectively. Examination of heart of rat from control group revealed no histopathological changes (Ctrl).
Iron accumulation in tissues-Data shown in
Histological examination of tissues-
On the other hand, heart of rat from group 1 showed myocarditis with mononuclear leucocytic cells infiltration (G1). However, heart of rat from group 2 showed no changes except slight intermuscular edema (G2). Vaculations of some cardiac myocytes was noticed in heart of rats from group 3 (G3). Meanwhile, hearts of rats from groups 4 and 5
showed no histopathological changes (G4) and (G5). The results of microscopically studied heart sections showed that the severe damage occurred in hearts of anemic rats in group 1 (G1), was completely recovered in rats of groups 4 and 5 (Fig.4C) .
Sections of spleens were stained with Perls' Prussian blue to evaluate iron accumulated in different groups. Fig.4D shows iron accumulated in spleens of rats from different groups.
Examination of spleens of rats from control group showed marked deposition of greenish blue hemosiderin pigment, indicating iron accumulated in tissues (Ctrl). Examined spleens of rats from group 2 showed a very few deposits in spleen tissues (G1). Moreover, the iron deposition in groups 2 and 3 was increased but still less than control group, (G2) and (G3).
However the iron deposition in spleen tissues from rats in groups 4 and 5 was clearly increased and recurred as control group, (G4) and (G5). These results support the results of iron accumulated in tissues of spleen of rats of different groups. . In humans, the capacity of iron absorption from the diet depends on various factors including the amount of iron in the body, the rate of erythrocyte production, the amount and kind of iron in the diet, and the presence of absorption enhancers and inhibitors in the diet [16] , [17] .
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Discussion
The histological study of tissues from liver, kidney, heart, and spleen of rats from different groups showed that the severe damage occurred in tissues of anemic rats group 1, was completely recovered after treatment by iron enriched yeast in groups 4 and 5.
However other treatments in groups 2 and 3 may require more time to achieve the same 
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Highlights
• Iron enriched yeast was prepared by cultivation of yeast cells at different iron concentrations and best concentration was determined with no effect of yeast growth or baking properties.
• Anemic rats were fed on different diets containing either inorganic iron salt or iron enriched yeast as iron source.
• Feeding efficiency and different haematological incidences were followed up for all groups.
• Histological study was performed for liver, heart, kidney and spleen tissues in all groups.
• Feeding anemic rats with supplemented yeast leads to better results in recovery from iron deficiency when compared to other diets containing inorganic iron salt as iron Tables   Table.1 
